Healthcare innovation is often associated with breakthrough medicines, advanced diagnostics and cutting-edge medical devices. Yet one of the most significant developments in recent years has emerged through software. Digital therapeutics, […]
- April 22, 2026
- By Daniel Molloy-Brookes
- Business
CRISPR Gene Editing: Advancing Precision Medicine in Modern Healthcare
The development of gene editing technologies has marked a significant shift in the way diseases are understood and potentially treated. Among these innovations, CRISPR has emerged as one of the […]
- February 18, 2026
- By Daniel Molloy-Brookes
- Business
Building Resilient Supply Chains in Life Sciences
Why supply chains matter in life sciences The life sciences sector relies on complex, interconnected supply chains to deliver medicines, diagnostics and medical technologies to patients. From raw materials and […]
- January 2, 2026
- By Daniel Molloy-Brookes
- Business
Opportunities and challenges in digital health adoption
Digital health at a turning point Digital health has moved from the margins of healthcare innovation to the centre of strategic planning across the UK. The growing use of digital […]
- November 12, 2025
- By Daniel Molloy-Brookes
- Business
Bridging the Gap Between Innovation and Impact: Implementation Science at Birmingham
Originally by: Amy Grove, Professor of Implementation Science, University of Birmingham Read the original here: https://www.linkedin.com/pulse/from-proof-concept-impact-how-implementation-tc3le/?trackingId=5d7TGbesSN%2BEqMkIJFR7Vg%3D%3D How do we ensure that innovations developed in health, education or social care make […]
- October 15, 2025
- By Daniel Molloy-Brookes
- Business
Fit for the Future: Familiar Promises in a New NHS Plan
The government’s new 10 Year Health Plan, Fit for the Future, was published on 3 July 2025. Heralded as a bold statement of intent, it promises three radical shifts: hospital […]
- July 24, 2025
- By Daniel Molloy-Brookes
- Business
Aston University and Max Healthcare India unite to advance global health research
Aston University has announced a major international partnership with Max Healthcare India, one of the country’s largest and most respected hospital networks. The two organisations have signed a memorandum of […]
- July 23, 2025
- By Daniel Molloy-Brookes
- Business
Health Data: How the UK’s Life Sciences Sector is Being Transformed
The UK government’s renewed focus on data-driven innovation in the life sciences sector marks a major shift in how health research, diagnostics and treatment are delivered. Central to this transformation […]
- July 21, 2025
- By Daniel Molloy-Brookes
- Business
Plans to boost life sciences manufacturing
A major pillar of the UK government’s new Life Sciences Sector Plan is a bold drive to boost domestic manufacturing of medical products, underpinned by a commitment of up to […]
- July 18, 2025
- By Daniel Molloy-Brookes
- Business
Government Unveils Life Sciences Sector Plan to Drive Innovation and NHS Reform
The UK government has launched a new Life Sciences Sector Plan, a ten-year strategy designed to boost the country’s position as a global leader in life sciences. Announced on Wednesday […]
- July 14, 2025
- By Daniel Molloy-Brookes
- Business
Joenja used by NHS patients for the first time
Joenja was approved by the MHRA in 2024 but was only issued to patients on the NHS for the first time in June. What is APDS? APDS (activated phosphoinositide 3-kinase […]
- July 3, 2025
- By Daniel Molloy-Brookes
- Business
Researchers find microbe that can break down toxic “forever chemical” PFAS
Researchers have found a way to absorb a toxic and long-lasting “forever chemical” which is often used in consumer goods. Used in various consumer products Products such as waterproof clothing, […]
- June 30, 2025
- By Daniel Molloy-Brookes
- Business
UK leads global charge to make AI safer in healthcare
In a landmark move that places the UK at the forefront of international health innovation, the country has become the first to join a new global network of regulators dedicated […]
- June 19, 2025
- By Daniel Molloy-Brookes
- Business
BioNTech $11bn cancer drug deal
An $11bn partnership between BioNTech and Bristol Myers Squibb has been signed. Potential competition to a leading drug The partnership involves the development of a cancer drug which could, potentially, […]
- May 16, 2025
- By Daniel Molloy-Brookes
- Business
Medilink Midlands Awards welcome Innovators and Experts
Medilink Midlands welcomed some of the region’s most innovative and interesting life sciences and health tech companies to their annual awards evening at the Grand Station in Wolverhampton on Thursday. […]














